Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 2/2010

01-02-2010 | Letter to the Editor

Toxic non-resorptive internal hydrocephalus as a result of haemorrhagic ventriculitis during induction chemotherapy of Bcr-Abl positive acute lymphoblastic leukaemia

Authors: Kalina Ramadanova, Hansjörg Hoff, Nicola Gökbuget, Ulrike Reuner, Susanne Hamann, Gerhard Ehninger, Markus Schaich

Published in: Annals of Hematology | Issue 2/2010

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Gökbuget N, Hoelzer D (1998) Meningeosis leukaemica in adult acute lymphoblastic leukaemia. J Neurooncol 38(2–3):167–180CrossRefPubMed
2.
Jabbour E, O’Brien S, Kantarjian H, Garcia-Manero G, Ferrajoli A, Ravandi F, Cabanillas M, Thomas DA (2007) Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukaemia. Blood 109(8):3214–3218CrossRefPubMed
3.
Watterson J, Toogood I, Nieder M, Morse M, Frierdich S, Lee Y, Moertel CL, Priest JR (1994) Excessive spinal cord toxicity from intensive central nervous system-directed therapies. Cancer 74(11):3034–3041CrossRefPubMed
4.
Tekkök IH, Carter DA, Robinson MG, Brinker R (1996) Reversal of CNS-prophylaxis-related leukoencephalopathy after CSF shunting: case histories of identical twins. Childs Nerv Syst 12(6):309–314CrossRefPubMed
5.
Thiessen B, DeAngelis LM (1998) Hydrocephalus in radiation leukoencephalopathy: results of ventriculoperitoneal shunting. Arch Neurol 55(5):705–710CrossRefPubMed
6.
Perrini P, Scollato A, Cioffi F, Mouchaty H, Conti R, Di Lorenzo N (2002) Radiation leukoencephalopathy associated with moderate hydrocephalus: intracranial pressure monitoring and results of ventriculoperitoneal shunting. Neurol Sci 23(5):237–241CrossRefPubMed
Metadata
Title
Toxic non-resorptive internal hydrocephalus as a result of haemorrhagic ventriculitis during induction chemotherapy of Bcr-Abl positive acute lymphoblastic leukaemia
Authors
Kalina Ramadanova
Hansjörg Hoff
Nicola Gökbuget
Ulrike Reuner
Susanne Hamann
Gerhard Ehninger
Markus Schaich
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 2/2010
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0781-z

Other articles of this Issue 2/2010

Annals of Hematology 2/2010 Go to the issue

Erratum

Long-term response to deferiprone therapy in Asian Indians

Original Article

Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells

Letter to the Editor

Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma

Original Article

Long-term response to deferiprone therapy in Asian Indians

Original Article

Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin

Original Article

Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits